2 Undervalued Pharmaceutical Stocks to Buy Now

Some investors love their dividends. Lucky for them, there are a lot of great companies that can afford to pay their shareholders cash every quarter. Pharma giants AbbVie (NYSE: ABBV) and GlaxoSmithKline (NYSE: GSK) boast high and sustainable dividend yields that are great for investors who want to see those dividends hit their account every three months. As a bonus, both stocks are undervalued today, and I think their total returns could outperform the market over the next few years. 

Image source: Getty Images.

Both AbbVie and GlaxoSmithKline have been beaten down over the last 12 months, and are still trading off of their highs from before the COVID-19 crash in March 2020. Despite growing earnings and raising its dividend over the past few years, AbbVie is 9% below its 2018 high of $123. GlaxoSmithKline, on the other hand, has been trading with some volatility for the past 12 months. After missing the mark on a potential COVID-19 vaccine, the company's shares still trade about 50% below the highs set back in 1999.

Continue reading

Source Fool.com